
Advancing Infectious Keratitis Treatment with Slit-Lamp CXL
Corneal Physician reports on ELZA’s exploration of slit-lamp CXL as a promising, accessible treatment for infectious keratitis.

Corneal Physician reports on ELZA’s exploration of slit-lamp CXL as a promising, accessible treatment for infectious keratitis.

Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.

Dr. Emilio Torres-Netto of the ELZA Institute was awarded the AAO Achievement Award at the 2024 Annual Meeting in Chicago, recognizing his contributions to ophthalmology through education, research, and service.

In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.

Larissa Paulasto shares her insights from the 19th International Myopia Conference in Sanya, China, where she discussed her research on myopia management lenses.

Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving visual outcomes

Dr. Dr. Torres-Netto explained to OSN how ELZA-STARK addresses astigmatism in patients with a history of radial keratotomy (RK).

Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress

The AAO-ESCRS Joint Symposium, convened leading ophthalmology experts to explore the latest developments in CXL.

Monday, September 9 is the last day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.